BRYNDIR
Live / Allowed — Fifth extension granted (statement of use) (as of 14 Sept 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 31 Mar 2023 filing date already counts against anyone who files later.
Record
- Serial number
- 97866864
- Mark type
- Word mark
- Filed
- 31 Mar 2023
- Published for opposition
- 30 Jan 2024
- Attorney of record
- Heather A. McDonald
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, infectious, inflammatory, kidney, liver, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular and viral diseases and disorders; pharmaceutical preparations for the treatment of blood disorders, bone growth disorders, skin disorders, arthritis, cancer, hypertension, pain, stroke, obesity and diabetes; pharmaceutical preparations, namely, anti-infective preparations, medicated dermatological preparations and smoking cessation preparations; vaccines for human use
Owner
Prosecution history
- 14 Sept 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 14 Sept 2026 — SOU EXTENSION 5 GRANTED
- 31 Jul 2026 — SOU EXTENSION 5 FILED
- 13 Sept 2026 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 31 Jul 2026 — SOU TEAS EXTENSION RECEIVED
- 03 Feb 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 02 Feb 2026 — SOU EXTENSION 4 GRANTED
- 02 Feb 2026 — SOU EXTENSION 4 FILED
- 02 Feb 2026 — SOU TEAS EXTENSION RECEIVED
- 01 Aug 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 01 Aug 2025 — SOU EXTENSION 3 GRANTED
- 01 Aug 2025 — SOU EXTENSION 3 FILED
- 01 Aug 2025 — SOU TEAS EXTENSION RECEIVED
- 31 Jan 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 31 Jan 2025 — SOU EXTENSION 2 GRANTED